Cancer Patients' vaccine protection under the microscope
NCT ID NCT06605625
Summary
This study aims to understand how well people with cancer build protective immunity after getting common vaccines for flu, COVID-19, and shingles. Researchers at Penn Medicine are enrolling 250 adult cancer patients who plan to receive these vaccines. The study will measure antibody levels in the blood before and after vaccination to see how the body's immune system responds.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for VIRAL VACCINES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Pennsylvania
Philadelphia, Pennsylvania, 19104, United States
Conditions
Explore the condition pages connected to this study.